SCHEMBL17577486

SCHEMBL17577486

B[C@@H]1O[C@H](CCP(=O)(OCC)OCC)C[C@@H]1O

nearest known ligand 0.40

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.40
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15988985 0.76 PPARD (0.32) PPARD
SCHEMBL19879917 0.75 PPARD (0.30) PPARD
SCHEMBL17577479 0.74 POLB (0.31)
SCHEMBL17159586 0.72
SCHEMBL15279168 0.70 FBP1 (0.46)
SCHEMBL19774555 0.69 PPARD (0.40) PPARDTSHR
SCHEMBL17577485 0.69
SCHEMBL25758493 0.68 PPARD (0.43) PPARDTSHR
SCHEMBL1592913 0.67 PPARD (0.50) PPARDTSHR
SCHEMBL17577492 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160068837-A1 SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES CONTAINING A 2' INTERNUCLEOSIDE LINKAGE SIRNA THERAPEUTICS, INC. (US) 2016-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068837-A1 SHORT INTERFERING NUCLEIC ACID (siNA) MOLECULES CONTAINING A 2' INTERNUCLEOSIDE LINKAGE NSUN2, AGO2, NSUN3 PPARD 4875/4885TSHR 4596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.